Alan Yuan
Managing Partner & Principal at Sol Energy Capital
United States
Alan Yuan, Managing Partner & Principal at Sol Energy Capital is an active investor based in United States. This profile covers what Alan Yuan backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VC
- Stages
- Early Stage VentureLate Stage Venture
- Invests in
- Climate & Energy
- Location
- United States
- Typical check
- $3.8M
How to reach Alan Yuan
Angels and operators like Alan Yuan reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Alan Yuan
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
What does Alan Yuan invest in?
Alan Yuan invests in Climate & Energy, typically at Early Stage Venture and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Alan Yuan invest at?
Alan Yuan typically invests at Early Stage Venture and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Alan Yuan's typical check size?
Alan Yuan typically writes checks around $3.8M. Use it as a signal for whether your raise fits their stage.
How do I contact Alan Yuan?
Unlock Alan Yuan's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.